IGF-1 DES

Description

High-Level Summary

IGF-1 DES (1-3) is a truncated version of Insulin-like Growth Factor-1 designed to have increased potency and receptor affinity. With a shorter amino acid sequence, IGF-1 DES demonstrates a stronger and faster activation of IGF-1 receptors, making it ideal for research focused on acute cell signaling and localized tissue repair.

– Form: Lyophilized peptide
– Purity: >99%
– Origin: Manufactured and tested in the USA
– Certifications: Certificate of Analysis (COA) included

Mechanism of Action (MOA)

IGF-1 DES works by rapidly binding to IGF-1 receptors, stimulating pathways that drive cell growth, proliferation, and tissue repair. Its enhanced binding affinity is due to the deletion of the first three amino acids from the IGF-1 sequence, which improves receptor activation and reduces interference by IGF-binding proteins.

Research Applications

– Acute muscle repair models
– Satellite cell activation studies
– Local tissue regeneration research
– Skin healing and wound response
– Short-acting anabolic peptide studies

Key Benefits for Research

– Rapid and potent receptor activation
– Ideal for short-term, localized research models
– Reduced binding to inhibitory IGF-binding proteins
– Higher bioactivity than standard IGF-1 in certain tissues

Certificate of Purity & Testing

Each vial is:
– Produced in a GMP-compliant U.S. facility
– Accompanied by a Certificate of Analysis (COA)
– Verified using HPLC and mass spectrometry
– Shipped with quality control documentation

Formulation & Dosage Info

– Contents: 1mg IGF-1 DES lyophilized powder
– Appearance: White or off-white powder
– Solubility: Reconstitute with sterile bacteriostatic water
– Storage: Store at -20°C; refrigerate after reconstitution and use within 30 days
*For research use only. Not for human or veterinary use.*

Legal & Compliance Notices

– For laboratory research use only
– Not intended for human consumption or medical use
– Buyer assumes all responsibility for use and handling